SILVERARC CAPITAL MANAGEMENT LLC 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-10 11:36 am Sale | 2025-12-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | SILVERARC CAPITAL MANAGEMENT LLC | 524,436 2.830% | -196,486 (-27.25%) | Filing |
| 2025-11-14 12:39 pm Purchase | 2025-09-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | SILVERARC CAPITAL MANAGEMENT LLC | 720,922 5.480% | 720,922 (New Position) | Filing |